RESTRUCTURING CHARGES AND SEPARATION COSTS

6 Months Ended

Jun. 30, 2025

Restructuring and Related Activities [Abstract]

RESTRUCTURING CHARGES AND SEPARATION COSTS

3. RESTRUCTURING CHARGES AND SEPARATION COSTS

In September 2024, the Company recorded an expense of $32.9 million related primarily to severance expenses associated with a global workforce realignment impacting approximately 2% of the Company's employees. The following table presents details of the restructuring liability, which is included in Accrued and Other Liabilities (in millions):

	Restructuring Liability
Balance at December 31, 2024	$	20.1
Payments	(9.8)
Balance at June 30, 2025	$	10.3

The Company's remaining severance obligations are expected to be substantially paid the second half of 2025.

In the three and six months ended June 30, 2025, the Company recorded expenses of $4.2 million and $8.4 million, respectively, primarily related to costs incurred for professional advisory services associated with the sale of Critical Care. For further information, see Note 4.